PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,653 Cr | ₹892 Cr | ₹1,005 Cr | ₹484 Cr | ₹766 Cr |
What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,653 Cr |
| Mar2025 | ₹892 Cr |
| Mar2024 | ₹1,005 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹766 Cr |
How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,653 Cr | 85.21 | |
| Mar2025 | ₹892 Cr | -11.17 | |
| Mar2024 | ₹1,005 Cr | 107.60 | |
| Mar2023 | ₹484 Cr | -36.86 | |
| Mar2022 | ₹766 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹28,429.9 Cr | 4.3% | 18.1% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 4.3% |
18.1% |
14% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses